Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers

Yo Mabuchi, Diarmaid D. Houlihan, Chihiro Akazawa, Hideyuki Okano, Yumi Matsuzaki

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) are currently defined as multipotent stromal cells that undergo sustained in vitro growth and can give rise to cells of multiple mesenchymal lineages, such as adipocytes, chondrocytes, and osteoblasts. The regenerative and immunosuppressive properties of MSCs have led to numerous clinical trials exploring their utility for the treatment of a variety of diseases (e.g., acute graft-versus-host disease, Crohn's disease, multiple sclerosis, osteoarthritis, and cardiovascular diseases including heart failure and myocardial infarction). On the other hand, conventionally cultured MSCs reflect heterogeneous populations that often contain contaminating cells due to the significant variability in isolation methods and the lack of specific MSC markers. This review article focuses on recent developments in the MSC research field, with a special emphasis on the identification of novel surface markers for the in vivo localization and prospective isolation of murine and human MSCs. Furthermore, we discuss the physiological importance of MSC subtypes in vivo with specific reference to data supporting their contribution to HSC niche homeostasis. The isolation of MSCs using selective markers (combination of PDGFRα and Sca-1) is crucial to address the many unanswered questions pertaining to these cells and has the potential to enhance their therapeutic potential enormously.

Original languageEnglish
Article number507301
JournalStem Cells International
DOIs
Publication statusPublished - 2013

Fingerprint

Mesenchymal Stromal Cells
Bone Marrow
Stem Cell Research
Acute Disease
Graft vs Host Disease
Immunosuppressive Agents
Stromal Cells
Chondrocytes
Osteoblasts
Adipocytes
Crohn Disease
Osteoarthritis
Multiple Sclerosis
Homeostasis
Cardiovascular Diseases
Heart Failure
Myocardial Infarction
Clinical Trials
Growth
Population

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. / Mabuchi, Yo; Houlihan, Diarmaid D.; Akazawa, Chihiro; Okano, Hideyuki; Matsuzaki, Yumi.

In: Stem Cells International, 2013.

Research output: Contribution to journalArticle

@article{60ab642da44c49b8848084f9177ad76d,
title = "Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers",
abstract = "Mesenchymal stem cells (MSCs) are currently defined as multipotent stromal cells that undergo sustained in vitro growth and can give rise to cells of multiple mesenchymal lineages, such as adipocytes, chondrocytes, and osteoblasts. The regenerative and immunosuppressive properties of MSCs have led to numerous clinical trials exploring their utility for the treatment of a variety of diseases (e.g., acute graft-versus-host disease, Crohn's disease, multiple sclerosis, osteoarthritis, and cardiovascular diseases including heart failure and myocardial infarction). On the other hand, conventionally cultured MSCs reflect heterogeneous populations that often contain contaminating cells due to the significant variability in isolation methods and the lack of specific MSC markers. This review article focuses on recent developments in the MSC research field, with a special emphasis on the identification of novel surface markers for the in vivo localization and prospective isolation of murine and human MSCs. Furthermore, we discuss the physiological importance of MSC subtypes in vivo with specific reference to data supporting their contribution to HSC niche homeostasis. The isolation of MSCs using selective markers (combination of PDGFRα and Sca-1) is crucial to address the many unanswered questions pertaining to these cells and has the potential to enhance their therapeutic potential enormously.",
author = "Yo Mabuchi and Houlihan, {Diarmaid D.} and Chihiro Akazawa and Hideyuki Okano and Yumi Matsuzaki",
year = "2013",
doi = "10.1155/2013/507301",
language = "English",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers

AU - Mabuchi, Yo

AU - Houlihan, Diarmaid D.

AU - Akazawa, Chihiro

AU - Okano, Hideyuki

AU - Matsuzaki, Yumi

PY - 2013

Y1 - 2013

N2 - Mesenchymal stem cells (MSCs) are currently defined as multipotent stromal cells that undergo sustained in vitro growth and can give rise to cells of multiple mesenchymal lineages, such as adipocytes, chondrocytes, and osteoblasts. The regenerative and immunosuppressive properties of MSCs have led to numerous clinical trials exploring their utility for the treatment of a variety of diseases (e.g., acute graft-versus-host disease, Crohn's disease, multiple sclerosis, osteoarthritis, and cardiovascular diseases including heart failure and myocardial infarction). On the other hand, conventionally cultured MSCs reflect heterogeneous populations that often contain contaminating cells due to the significant variability in isolation methods and the lack of specific MSC markers. This review article focuses on recent developments in the MSC research field, with a special emphasis on the identification of novel surface markers for the in vivo localization and prospective isolation of murine and human MSCs. Furthermore, we discuss the physiological importance of MSC subtypes in vivo with specific reference to data supporting their contribution to HSC niche homeostasis. The isolation of MSCs using selective markers (combination of PDGFRα and Sca-1) is crucial to address the many unanswered questions pertaining to these cells and has the potential to enhance their therapeutic potential enormously.

AB - Mesenchymal stem cells (MSCs) are currently defined as multipotent stromal cells that undergo sustained in vitro growth and can give rise to cells of multiple mesenchymal lineages, such as adipocytes, chondrocytes, and osteoblasts. The regenerative and immunosuppressive properties of MSCs have led to numerous clinical trials exploring their utility for the treatment of a variety of diseases (e.g., acute graft-versus-host disease, Crohn's disease, multiple sclerosis, osteoarthritis, and cardiovascular diseases including heart failure and myocardial infarction). On the other hand, conventionally cultured MSCs reflect heterogeneous populations that often contain contaminating cells due to the significant variability in isolation methods and the lack of specific MSC markers. This review article focuses on recent developments in the MSC research field, with a special emphasis on the identification of novel surface markers for the in vivo localization and prospective isolation of murine and human MSCs. Furthermore, we discuss the physiological importance of MSC subtypes in vivo with specific reference to data supporting their contribution to HSC niche homeostasis. The isolation of MSCs using selective markers (combination of PDGFRα and Sca-1) is crucial to address the many unanswered questions pertaining to these cells and has the potential to enhance their therapeutic potential enormously.

UR - http://www.scopus.com/inward/record.url?scp=84878706839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878706839&partnerID=8YFLogxK

U2 - 10.1155/2013/507301

DO - 10.1155/2013/507301

M3 - Article

C2 - 23766770

AN - SCOPUS:84878706839

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 507301

ER -